Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers (NiNbI)

October 15, 2019 updated by: Marc Raes, Hasselt University

Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers Based on Biomarker Profiles in Exhaled Breath and Nasal Mucus and Based on Breath Sound Analysis

Almost 50% of all children have at least 1 episode of noisy breathing before the age of 2 years and almost 25% of these children have more episodes of noisy breathing. The lack of an objective technique for diagnosing noisy breathing children often leads to overrated diagnosis of "wheezing", whereas there may be other noisy breathing phenotypes, like "rattling", that don't favor from the same therapeutic treatment. Presumably, different underlying pathophysiological mechanisms are involved with different biomarker profiles characteristic for different phenotypes. The goal of this study is to optimize the diagnosis of noisy breathing infants and toddlers. Children will be followed for a treatment period of 6 weeks and will visit the paediatrician 3 times (week 0, 3 and 6). During the consultations breath sound analysis will be performed and a breath sample and a nasal mucus will be collected to analyse biomarker profiles. Both methods for diagnosing noisy breathing infants are non-invasive and will be compared to the standard procedure of the paediatrician which consists of auscultation and palpation of the chest. An objective and non-invasive method for diagnosing noisy breathing infants and toddler will pave the way for more cost-effective and personalized prescription of therapies which will increase the quality of life of children with noisy breathing.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • clinical diagnosis of noisy breathing ("wheezing" or "rattling")

Exclusion Criteria:

  • born before pregnancy week 37
  • congenital or genetic conditions (Down syndrome, Klinefelter's syndrome, …)
  • acquired chronic respiratory diseases (bronchopulmonary dysplasy, lung fibrosis, …)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Wheezing
breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.
Other: Rattling
breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: week 0
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.
week 0
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: week 3
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.
week 3
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: Week 6
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.
Week 6
exhaled breath volatiles
Time Frame: week 0
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
week 0
exhaled breath volatiles
Time Frame: week 3
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
week 3
exhaled breath volatiles
Time Frame: week 6
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
week 6
respiratory pathogens
Time Frame: week 0
respiratory pathogens present in a nasopharyngeal swab detected using PCR
week 0
respiratory pathogens
Time Frame: week 3
respiratory pathogens present in a nasopharyngeal swab detected using PCR
week 3
respiratory pathogens
Time Frame: week 6
respiratory pathogens present in a nasopharyngeal swab detected using PCR
week 6
level of inflammation markers
Time Frame: week 0
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
week 0
level of inflammation markers
Time Frame: week 3
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
week 3
level of inflammation markers
Time Frame: week 6
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 0
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
week 0
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 3
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
week 3
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 6
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
week 6
Treatment response assessed by online journal for parents
Time Frame: week 6
Parents are asked what type of noisy breathing symptoms their child had during the day. Options are: (1) Wheezing; (2) Rattling; (3) Both, but mostly wheezing; (4) Both, but mostly rattling; (5) Both in equal amounts, (6) No noisy breathing today. In the online questionnaire sound fragments of wheezing and rattling are available incase parents are in doubt.
week 6
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 3 months after week 6
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online
3 months after week 6
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 6 months after week 6
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online
6 months after week 6
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 9 months after week 6
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online
9 months after week 6
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 12 months after week 6
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online
12 months after week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Marc Raes, prof. dr., Jessa Hospital
  • Study Chair: Gitte Slingers, drs., Hasselt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2018

Primary Completion (Anticipated)

March 1, 2020

Study Completion (Anticipated)

May 1, 2020

Study Registration Dates

First Submitted

August 27, 2019

First Submitted That Met QC Criteria

October 15, 2019

First Posted (Actual)

October 16, 2019

Study Record Updates

Last Update Posted (Actual)

October 16, 2019

Last Update Submitted That Met QC Criteria

October 15, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wheezing

Clinical Trials on diagnosing noisy breathing in infants and toddlers

3
Subscribe